783Wire StoriesShardul Amarchand Mangaldas & Co. Enables Work from Anywhere with Citrix®
Leading law firm uses digital workspace solutions to deliver consistent, secure and reliable experience that empowers employees to perform at their best...
- 719Wire Stories
Intercontinental Exchange Launches 10 New MSCI® Index Futures
Four New Contracts Help Manage Climate Risk and Are Only Available on ICE Futures U.S. The Additional Six Contracts Provide Specific Regional...
- 928Wire Stories
TROPION-Lung01 Head-to-Head Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan Versus Docetaxel in Previously Treated Patients with Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of TROPION-Lung01,...
- 1.0KWire Stories
TROPION-Lung05 Phase 2 Trial of Datopotamab Deruxtecan Initiated in Patients with Advanced or Metastatic NSCLC with Actionable Genomic Alterations
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of TROPION-Lung05,...
- 749Wire Stories
ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore
– Hillhouse-backed Overland Pharmaceuticals to initially contribute $50 million to fund operations and development LAUSANNE, Switzerland & SHANGHAI & BOSTON–(BUSINESS WIRE)–ADC Therapeutics...
- 735Wire Stories
Can-Fite Reports on Progress With Its Namodenoson NASH Program
Top NASH U.S. Key Opinion Leaders advise on the design of a Phase IIb protocol Manufacturing of Namodenoson for the Phase IIb...
- 779Wire Stories
Gravity Launches an Idle Casual RPG ‘Poring Merge’ for the First Time in Brazil
A new idle casual RPG that anyone can easily enjoy With pre-registration by over 300,000 users, it is expected to gain high...
- 648Wire Stories
EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad...
- 794Wire Stories
FPT Software Recognized in Gartner’s 2020 Market Guide for Public Cloud Managed and Professional Services Providers, Asia/Pacific
HANOI, Vietnam–(BUSINESS WIRE)–Vietnam’s leading ICT firm, FPT Software, has recently been listed in Gartner’s 2020 Market Guide for Public Cloud Managed...
- 853Wire Stories
Arkema Announces the Proposed Divestment of Its PMMA Business to Trinseo
Arkema announces the proposed divestment of its PMMA business to Trinseo for an enterprise value of €1,137 million. This project is a...
